KO-947 - Kura Oncology
Zarnestra (tipifarnib) - Kura Oncology
Menin MLL inhibitors - Kura Oncology
http://globenewswire.com/news-release/2019/02/26/1742289/0/en/Kura-Oncology-to-Report-Fourth-Quarter-and-Full-Year-2018-Financial-Results.html
 
Feb 26, 2019
 
Prev Next